| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8789916 | Urologic Oncology: Seminars and Original Investigations | 2018 | 7 Pages |
Abstract
Metric substaging of T1BC was possible in all cases of 601 T1BC patients and it was a strong independent prognosticator of both PFS and CSS.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Elisabeth E. M.D., Wolfgang M.D., Arndt M.D., Ph.D., Simone M.D., Ph.D., Roman M.D., Johannes M.D., Johannes M.D., Quentin M.D., Eva M. M.D., Ph.D., Joost L. M.D., Ph.D., Judith M.D., Michael A.S. M.D., F.A.C.S., F.R.C.S.C., Robert M.D., Ph.D.,